These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator. Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936 [TBL] [Abstract][Full Text] [Related]
27. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain. Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181 [TBL] [Abstract][Full Text] [Related]
28. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death. Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007 [TBL] [Abstract][Full Text] [Related]
29. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide. Decristoforo C; Mather SJ Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875 [TBL] [Abstract][Full Text] [Related]
30. Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m. Mitsui K; Taki T; Miyagawa Y; Yamada Y; Honda N; Fukatsu H; Yoshikawa K; Segawa A Hinyokika Kiyo; 1995 Aug; 41(8):593-601. PubMed ID: 7572438 [TBL] [Abstract][Full Text] [Related]
31. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies. Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859 [TBL] [Abstract][Full Text] [Related]
32. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications. Reilly RM; Scollard DA; Wang J; Mondal H; Chen P; Henderson LA; Bowen BM; Vallis KA J Nucl Med; 2004 Apr; 45(4):701-8. PubMed ID: 15073268 [TBL] [Abstract][Full Text] [Related]
33. Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ Bioconjug Chem; 1992; 3(2):91-9. PubMed ID: 1515475 [No Abstract] [Full Text] [Related]
34. Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides. Najafi A; Alauddin MM; Siegel ME; Epstein AL Int J Rad Appl Instrum B; 1991; 18(2):179-85. PubMed ID: 2026493 [TBL] [Abstract][Full Text] [Related]
35. Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran. Sundberg AL; Blomquist E; Carlsson J; Steffen AC; Gedda L Nucl Med Biol; 2003 Apr; 30(3):303-15. PubMed ID: 12745022 [TBL] [Abstract][Full Text] [Related]
36. Multimodality imaging of the HER-kinase axis in cancer. Cai W; Niu G; Chen X Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):186-208. PubMed ID: 17846765 [TBL] [Abstract][Full Text] [Related]
37. Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate. Behe M; Du J; Becker W; Behr T; Angerstein C; Márquez M; Hiltunen J; Nilsson S; Holmberg AR Med Oncol; 2001; 18(1):59-64. PubMed ID: 11778971 [TBL] [Abstract][Full Text] [Related]
38. Labeling of polypeptides with technetium-99m using a dextran spacer. Holmberg A; Marquez M; Westlin JE; Nilsson S Cancer Res; 1995 Dec; 55(23 Suppl):5710s-5713s. PubMed ID: 7493332 [TBL] [Abstract][Full Text] [Related]
39. Technetium-99m labelling of glycosylated somatostatin-14. Du J; Hiltunen J; Marquez M; Nilsson S; Holmberg AR Appl Radiat Isot; 2001 Aug; 55(2):181-7. PubMed ID: 11393758 [TBL] [Abstract][Full Text] [Related]